
Enovix Corporation (ENVX) Stock Forecast & Price Target
Enovix Corporation (ENVX) Analyst Ratings
Bulls say
Enovix is viewed favorably because its core BreakFlow and Encapsulation technologies are translating into tangible commercial traction, with 3Q26 revenue of $11.0M up 38% Y/Y and drone and defense customers contributing about 70% of sales, while gross margin reached a record 34.5%. Its 2027 outlook looks especially compelling, with revenue guided to $65–85M, nearly half of the midpoint already in backlog, a $216M drone, defense, and industrial pipeline, and $19M of Korean capacity expansion expected to support higher-volume, secure non-China supply. The balance sheet also improved after retiring $128M of 4.75% 2030 notes for about $81.4M and holding roughly $415M of cash, giving it more flexibility to fund growth despite still-negative EBITDA.
Bears say
Enovix is facing a weakened fundamental outlook because its previously core smartphone opportunity has been pushed out again, with AI-1 not moving into field testing and AI-2 still lacking a timeline, leaving no near-term path to filling Fab2 at scale. Although 3Q revenue rose 38% year over year to $11.0M, adjusted EBITDA was still $(21.1M), 4Q revenue guidance of $9–10M is below prior expectations, and the model still points to adjusted EBITDA breakeven beyond 2028. Execution risk remains elevated as the company relies on unproven manufacturing scale, a delayed 50k-pack smart-eyewear order now expected in 1H27, and financing flexibility ahead of the $172.5M 2028 maturity.
This aggregate rating is based on analysts' research of Enovix Corporation and is not a guaranteed prediction by Public.com or investment advice.
Enovix Corporation (ENVX) Analyst Forecast & Price Prediction
Start investing in Enovix Corporation (ENVX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Enovix Corporation (ENVX) Forecast
Enovix Corporation (ENVX) Analyst Forecast & Price Prediction
Start investing in Enovix Corporation (ENVX)
Order type
Buy in
Order amount
Est. shares
0 shares